| Value | ₹1,800 Cr |
|---|
BSE filing, NSE: BBL. Summary written from the filing by ALFA Finder's alert engine.
Bharat Bijlee Ltd: key numbers
- Share price
- ₹2,449.20
- Market cap
- ₹2,768 Cr
- Revenue (annual)
- ₹2,274 Cr
- Net profit (annual)
- ₹120.1 Cr
- P/E (TTM)
- 21.4×Sector 41.2×
- Promoter holding
- 33.65%+0.00% QoQ
- FII holding
- 4.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharat Bijlee Ltd
All →Bharat Bijlee Q2 FY27 Results: Net Profit ₹46 Cr, Up 63.1% YoY
Bharat Bijlee Ltd reported revenue from operations of ₹736.2 Cr (+55.5% YoY) and net profit of ₹46 Cr (+63.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹46 Cr · +63.1% YoY
Bharat Bijlee Other Announcement
Bharat Bijlee Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI Regulation 31.
Bharat Bijlee Legal & Regulatory
Bharat Bijlee received an income tax demand order for ₹58.31 Lakhs (₹0.58 Crore). The company plans to discharge the demand as per the Income Tax Act.
- Value
- ₹0.58 Cr
Bharat Bijlee Board Meeting Date
Bharat Bijlee has scheduled a board meeting on 27 October 2026 to consider unaudited standalone H1 FY27 results. No financial figures are disclosed.
Bharat Bijlee Legal & Regulatory
Bharat Bijlee received a ₹0.05 Crore penalty from the Income Tax Department under Section 270A for AY 2020-21. The penalty relates to MAT credit disallowance.
- Value
- ₹0.05 Cr
Bharat Bijlee Management Change
Bharat Bijlee Limited announced changes in senior management, including the retirement of R. Rajaraman and new designations for Khushru M. Vakharia and Ashwinikumar V. Sathe.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.